Cargando…

Structure and Content of Drug Monitoring Advices Included in Discharge Letters at Interfaces of Care: Exploratory Analysis Preceding Database Development

BACKGROUND: Inadequate drug monitoring of drug therapy after hospital discharge facilitates adverse drug events and preventable hospital readmissions. OBJECTIVE: This study aimed to analyze the structure and content of drug monitoring advices of a representative sample of discharge letters as a basi...

Descripción completa

Detalles Bibliográficos
Autores principales: Morath, Benedict, Wien, Katharina, Hoppe-Tichy, Torsten, Haefeli, Walter Emil, Seidling, Hanna Marita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6475819/
https://www.ncbi.nlm.nih.gov/pubmed/30958278
http://dx.doi.org/10.2196/10832
_version_ 1783412810462527488
author Morath, Benedict
Wien, Katharina
Hoppe-Tichy, Torsten
Haefeli, Walter Emil
Seidling, Hanna Marita
author_facet Morath, Benedict
Wien, Katharina
Hoppe-Tichy, Torsten
Haefeli, Walter Emil
Seidling, Hanna Marita
author_sort Morath, Benedict
collection PubMed
description BACKGROUND: Inadequate drug monitoring of drug therapy after hospital discharge facilitates adverse drug events and preventable hospital readmissions. OBJECTIVE: This study aimed to analyze the structure and content of drug monitoring advices of a representative sample of discharge letters as a basis for future electronic information systems. METHODS: On 2 days in November 2016, all discharge letters of 3 departments of a university hospital were extracted from the hospital information system. The frequency, content, and structure of drug monitoring advices in discharge letters were investigated and compared with the theoretical monitoring requirements expressed in the corresponding summaries of product characteristics (SmPC). The quality of the drug monitoring advices in the discharge letters was rated with the domains of an adapted systematic instructions for monitoring (SIM) score. RESULTS: In total, 154 discharge letters were analyzed containing 1180 brands (240 active pharmaceutical substances), of which 50.42% (595/1180) could theoretically be amended with a monitoring advice according to the SmPC. In reality, 40 discharge letters (26.0%, 40/154) contained a total of 66 monitoring advices for 57 brands (4.83%, 57/1180), comprising 18 different monitoring parameters. Drug monitoring advices only addressed mean 1.9 (SD 0.8) of the 7 domains of the SIM score and frequently did not address reasons for monitoring (86%, 57/66), the timing of monitoring, that is, the start (76%, 50/66), the frequency (94%, 63/66), the stop (95%, 63/66), and how to react (83%, 55/66). CONCLUSIONS: Drug monitoring advices were mostly absent in discharge letters and a gold standard for appropriate drug monitoring advices was lacking. Hence, more effort should be put in the development of tools that facilitate easy presentation of clinically meaningful drug monitoring advices at the point of care.
format Online
Article
Text
id pubmed-6475819
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher JMIR Publications
record_format MEDLINE/PubMed
spelling pubmed-64758192019-05-08 Structure and Content of Drug Monitoring Advices Included in Discharge Letters at Interfaces of Care: Exploratory Analysis Preceding Database Development Morath, Benedict Wien, Katharina Hoppe-Tichy, Torsten Haefeli, Walter Emil Seidling, Hanna Marita JMIR Med Inform Original Paper BACKGROUND: Inadequate drug monitoring of drug therapy after hospital discharge facilitates adverse drug events and preventable hospital readmissions. OBJECTIVE: This study aimed to analyze the structure and content of drug monitoring advices of a representative sample of discharge letters as a basis for future electronic information systems. METHODS: On 2 days in November 2016, all discharge letters of 3 departments of a university hospital were extracted from the hospital information system. The frequency, content, and structure of drug monitoring advices in discharge letters were investigated and compared with the theoretical monitoring requirements expressed in the corresponding summaries of product characteristics (SmPC). The quality of the drug monitoring advices in the discharge letters was rated with the domains of an adapted systematic instructions for monitoring (SIM) score. RESULTS: In total, 154 discharge letters were analyzed containing 1180 brands (240 active pharmaceutical substances), of which 50.42% (595/1180) could theoretically be amended with a monitoring advice according to the SmPC. In reality, 40 discharge letters (26.0%, 40/154) contained a total of 66 monitoring advices for 57 brands (4.83%, 57/1180), comprising 18 different monitoring parameters. Drug monitoring advices only addressed mean 1.9 (SD 0.8) of the 7 domains of the SIM score and frequently did not address reasons for monitoring (86%, 57/66), the timing of monitoring, that is, the start (76%, 50/66), the frequency (94%, 63/66), the stop (95%, 63/66), and how to react (83%, 55/66). CONCLUSIONS: Drug monitoring advices were mostly absent in discharge letters and a gold standard for appropriate drug monitoring advices was lacking. Hence, more effort should be put in the development of tools that facilitate easy presentation of clinically meaningful drug monitoring advices at the point of care. JMIR Publications 2019-04-08 /pmc/articles/PMC6475819/ /pubmed/30958278 http://dx.doi.org/10.2196/10832 Text en ©Benedict Morath, Katharina Wien, Torsten Hoppe-Tichy, Walter Emil Haefeli, Hanna Marita Seidling. Originally published in JMIR Medical Informatics (http://medinform.jmir.org), 08.04.2019. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Medical Informatics, is properly cited. The complete bibliographic information, a link to the original publication on http://medinform.jmir.org/, as well as this copyright and license information must be included.
spellingShingle Original Paper
Morath, Benedict
Wien, Katharina
Hoppe-Tichy, Torsten
Haefeli, Walter Emil
Seidling, Hanna Marita
Structure and Content of Drug Monitoring Advices Included in Discharge Letters at Interfaces of Care: Exploratory Analysis Preceding Database Development
title Structure and Content of Drug Monitoring Advices Included in Discharge Letters at Interfaces of Care: Exploratory Analysis Preceding Database Development
title_full Structure and Content of Drug Monitoring Advices Included in Discharge Letters at Interfaces of Care: Exploratory Analysis Preceding Database Development
title_fullStr Structure and Content of Drug Monitoring Advices Included in Discharge Letters at Interfaces of Care: Exploratory Analysis Preceding Database Development
title_full_unstemmed Structure and Content of Drug Monitoring Advices Included in Discharge Letters at Interfaces of Care: Exploratory Analysis Preceding Database Development
title_short Structure and Content of Drug Monitoring Advices Included in Discharge Letters at Interfaces of Care: Exploratory Analysis Preceding Database Development
title_sort structure and content of drug monitoring advices included in discharge letters at interfaces of care: exploratory analysis preceding database development
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6475819/
https://www.ncbi.nlm.nih.gov/pubmed/30958278
http://dx.doi.org/10.2196/10832
work_keys_str_mv AT morathbenedict structureandcontentofdrugmonitoringadvicesincludedindischargelettersatinterfacesofcareexploratoryanalysisprecedingdatabasedevelopment
AT wienkatharina structureandcontentofdrugmonitoringadvicesincludedindischargelettersatinterfacesofcareexploratoryanalysisprecedingdatabasedevelopment
AT hoppetichytorsten structureandcontentofdrugmonitoringadvicesincludedindischargelettersatinterfacesofcareexploratoryanalysisprecedingdatabasedevelopment
AT haefeliwalteremil structureandcontentofdrugmonitoringadvicesincludedindischargelettersatinterfacesofcareexploratoryanalysisprecedingdatabasedevelopment
AT seidlinghannamarita structureandcontentofdrugmonitoringadvicesincludedindischargelettersatinterfacesofcareexploratoryanalysisprecedingdatabasedevelopment